Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizons
Colorectal cancer (CRC) continues to be one of the most prevalent and lethal cancers worldwide. Over the past decades, immune checkpoint inhibitors (ICIs) have shown to significantly improve patient outcomes in mismatch repair-deficient metastasized CRC. However, widening the scope of this novel tre...
Main Authors: | Jan Clerick, Aude Van Oosterwyck, Saskia Carton |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294224000194 |
Similar Items
-
Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade
by: Alecsandra Gorzo, et al.
Published: (2022-02-01) -
General treatment for metastatic colorectal cancer: From KEYNOTE 177 study
by: Yuwei Ding, et al.
Published: (2021-08-01) -
Case report: A combined immunotherapy strategy as a promising therapy for MSI-H colorectal carcinomas with multiple HPD risk factors
by: Jinli Zhang, et al.
Published: (2023-05-01) -
Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
by: Long Zhou, et al.
Published: (2023-01-01) -
An Insight into Deficient Mismatch Repair Colorectal Cancer Screening in a Romanian Population—A Bi-Institutional Pilot Study
by: Cristina Lungulescu, et al.
Published: (2021-08-01)